Andrew Eisenberger Selected Research

Heparin (Liquaemin)

1/2021	Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy.
1/2018	Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia.
12/2015	Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Eisenberger Research Topics

Disease

7	Hemorrhage 07/2023 - 10/2014
4	Venous Thromboembolism 05/2017 - 07/2014
3	Heart Failure 01/2023 - 07/2008
3	COVID-19 01/2021 - 01/2020
3	Thrombocytopenia (Thrombopenia) 01/2018 - 12/2015
3	Hemolysis 01/2017 - 11/2016
2	Hypertension (High Blood Pressure) 01/2023 - 07/2008
2	Immunoglobulin Light-chain Amyloidosis 12/2021 - 01/2019
2	Cerebral Hemorrhage 01/2019 - 09/2014
2	Hematoma 01/2019 - 01/2019
1	Hemophilia A (Haemophilia) 07/2023
1	Primary Graft Dysfunction 01/2023
1	Infections 01/2023
1	Amyloid Plaque 12/2021
1	Glucosephosphate Dehydrogenase Deficiency 01/2020
1	IgA Deficiency 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Human Influenza (Influenza) 01/2020
1	Thrombosis (Thrombus) 01/2017
1	Plague (Bubonic Plague) 09/2016
1	Respiratory Insufficiency (Respiratory Failure) 05/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016
1	Thrombophilia 10/2014
1	Ischemic Stroke 09/2014
1	Pulmonary Embolism 07/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2014
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2008
1	Cardiotoxicity 07/2008
1	Heart Diseases (Heart Disease) 07/2008
1	Neoplasms (Cancer) 06/2006

Drug/Important Bio-Agent (IBA)

3	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 12/2015
2	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 11/2016
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2017
2	Oral ContraceptivesIBA 05/2017 - 01/2016
1	AutoantibodiesIBA 07/2023
1	Factor VIII (Coagulation Factor VIII)IBA 07/2023
1	Hormones (Hormone)IBA 01/2023
1	Prostaglandins DIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 12/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Ritonavir (Norvir)FDA Link 01/2020
1	remdesivirIBA 01/2020
1	Lopinavir FDA Link 01/2020
1	AnticoagulantsIBA 01/2019
1	monoclonal antibody 11-1f4IBA 01/2019
1	Abciximab (ReoPro)FDA Link 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	IronIBA 01/2017
1	BilirubinIBA 01/2017
1	Contraceptive Agents (Contraceptives)IBA 01/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	Anesthetics (Anesthetic Agents)IBA 10/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2008
1	AnthracyclinesIBA 07/2008
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2006
1	Attenuated VaccinesIBA 06/2006
1	Viral VaccinesIBA 06/2006
1	Cancer VaccinesIBA 06/2006

Therapy/Procedure

6	Therapeutics 01/2023 - 09/2016
4	Heart-Assist Devices 01/2018 - 09/2016
3	Extracorporeal Membrane Oxygenation 01/2020 - 12/2015
1	Length of Stay 01/2023
1	Heart Transplantation (Grafting, Heart) 01/2023
1	Thrombolytic Therapy 01/2021
1	Investigational Therapies (Experimental Therapy) 01/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Platelet Transfusion (Blood Platelet Transfusions) 05/2016
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 07/2014
1	Drug Therapy (Chemotherapy) 07/2008
1	Immunotherapy 06/2006